Buildablock Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Buildablock Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2011 | $134.4K | Dec 1, 2023 |
| FY2011 | Nov 30, 2010 | $188.9K | Feb 27, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | ($1.04M) | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | ($860.5K) | Dec 1, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | ($1.04M) | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | ($729.1K) | Dec 1, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | $257.6K | Dec 1, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | $372.0K | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | $35.2K | Dec 1, 2023 |
| FY2011 | Nov 30, 2010 | $168.7K | Feb 27, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | $132.0K | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | $2.61M | Dec 1, 2023 |
| FY2011 | Nov 30, 2010 | $2.22M | Feb 27, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | $240.0K | Dec 1, 2023 |
| FY2012 | Apr 30, 2012 | ($291.1K) | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | ($2.58M) | Dec 1, 2023 |
| FY2012 | Nov 30, 2010 | ($2.05M) | Dec 1, 2023 |
| FY2012 | Nov 30, 2009 | ($1.53M) | Dec 1, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | ($1.88M) | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | ($4.15M) | Dec 1, 2023 |
| FY2011 | Nov 30, 2010 | ($3.29M) | Feb 27, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | 0 | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | 0 | Dec 1, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | 0 | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | 0 | Dec 1, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Nov 30, 2012 | 23.94M | Dec 1, 2023 |
| FY2012 | Nov 30, 2011 | 8.56M | Dec 1, 2023 |